- In September 2024, BASF SE introduced a new range of high-concentrate EPA supplements designed to support cardiovascular health, as part of the company’s broader strategy to leverage the rising consumer demand for potent omega-3 solutions. This development is expected to enhance BASF’s position in the growing eicosapentaenoic acid market
- In August 2024, Koninklijke DSM N.V. announced the expansion of its algal oil production facilities to meet the surging demand for plant-based omega-3 products, especially among vegan and environmentally conscious consumers. This strategic move reinforces DSM’s commitment to offering sustainable alternatives within the global omega-3 market
- In July 2024, Cargill, Inc. unveiled a new EPA and DHA omega-3 blend specifically designed for fortified beverages, catering to the rapidly expanding functional food and drink segment. With a focus on cardiovascular and cognitive health, this launch is expected to broaden Cargill’s product portfolio and market reach
- In September 2021, KD Pharma Group launched Alga3, a vegan omega-3 formulation created using advanced technology to customize EPA and DHA ratios. This innovation offers a sustainable, plant-based alternative to traditional fish oil, strengthening KD Pharma's role in diversifying the eicosapentaenoic acid market
- In June 2021, Polaris introduced Omegavie DHA 800 Sensory Qualitysilver 5, a premium algae oil rich in vitamins and proteins, designed as a sustainable source of PUFAs. This plant-based solution enhances the sensory quality of omega-3 products, contributing to the market’s shift toward environmentally friendly alternatives
